brilinta

Generic: ticagrelor

Labeler: cardinal health 107, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name brilinta
Generic Name ticagrelor
Labeler cardinal health 107, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

ticagrelor 90 mg/1

Manufacturer
Cardinal Health 107, LLC

Identifiers & Regulatory

Product NDC 55154-9618
Product ID 55154-9618_abe4e6b8-c0d0-44ec-b393-d8b467796497
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA022433
Listing Expiration 2027-12-31
Marketing Start 2011-08-05

Pharmacologic Class

Established (EPC)
p2y12 platelet inhibitor [epc]
Mechanism of Action
p2y12 receptor antagonists [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]
Physiologic Effect
decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 551549618
Hyphenated Format 55154-9618

Supplemental Identifiers

RxCUI
1116635 1116639
UPC
0355154961883
UNII
GLH0314RVC
NUI
N0000182142 N0000008832 N0000182143 N0000182141 N0000185503

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name brilinta (source: ndc)
Generic Name ticagrelor (source: ndc)
Application Number NDA022433 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 90 mg/1
source: ndc
Packaging
  • 10 BLISTER PACK in 1 BAG (55154-9618-0) / 1 TABLET in 1 BLISTER PACK
  • 1440 TABLET in 1 BOTTLE, PLASTIC (55154-9618-8)
source: ndc

Packages (2)

Ingredients (1)

ticagrelor (90 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "abe4e6b8-c0d0-44ec-b393-d8b467796497", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "upc": ["0355154961883"], "unii": ["GLH0314RVC"], "rxcui": ["1116635", "1116639"], "spl_set_id": ["4f9bd52a-99a7-4606-92b4-456a917aabef"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Cardinal Health 107, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "10 BLISTER PACK in 1 BAG (55154-9618-0)  / 1 TABLET in 1 BLISTER PACK", "package_ndc": "55154-9618-0", "marketing_start_date": "20110805"}, {"sample": false, "description": "1440 TABLET in 1 BOTTLE, PLASTIC (55154-9618-8)", "package_ndc": "55154-9618-8", "marketing_start_date": "20110805"}], "brand_name": "BRILINTA", "product_id": "55154-9618_abe4e6b8-c0d0-44ec-b393-d8b467796497", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "55154-9618", "generic_name": "Ticagrelor", "labeler_name": "Cardinal Health 107, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BRILINTA", "active_ingredients": [{"name": "TICAGRELOR", "strength": "90 mg/1"}], "application_number": "NDA022433", "marketing_category": "NDA", "marketing_start_date": "20110805", "listing_expiration_date": "20271231"}